Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
The European Bank for Reconstruction and Development (EBRD) is lending €30 million to Timişoara to co-finance priority investments in its district heating network.
New orders in the total manufacturing industry (domestic and foreign markets) saw a nominal decrease in August 2025, falling by 28.5% compared to July 2025.
Romania has secured the European Commission's agreement to replace the National Recovery and Resilience Plan (PNRR) milestone concerning the reduction of the VAT gap.
Flyone Airlines is continuing its growth trajectory in the Romanian market, announcing the launch of seven new direct routes from Henri Coandă – Otopeni International Airport.
The latest series of Fidelis government bonds, issued by the Ministry of Finance, have been listed on the Bucharest Stock Exchange (BVB).